You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
|
|---|---|
| Published in |
New England Journal of Medicine, March 2005
|
| DOI | 10.1056/nejmoa043330 |
| Pubmed ID | |
| Authors |
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C Janzer, Samuel K Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J Gregory Cairncross, Elizabeth Eisenhauer, René O Mirimanoff |
| Abstract |
Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for newly diagnosed glioblastoma is surgical resection to the extent feasible, followed by adjuvant radiotherapy. In this trial we compared radiotherapy alone with radiotherapy plus temozolomide, given concomitantly with and after radiotherapy, in terms of efficacy and safety. |
X Demographics
The data shown below were collected from the profiles of 41 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 34% |
| India | 3 | 7% |
| Spain | 3 | 7% |
| United Kingdom | 2 | 5% |
| South Africa | 1 | 2% |
| Saudi Arabia | 1 | 2% |
| Denmark | 1 | 2% |
| New Zealand | 1 | 2% |
| Canada | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 14 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 29 | 71% |
| Scientists | 6 | 15% |
| Practitioners (doctors, other healthcare professionals) | 4 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 4,880 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 39 | <1% |
| Japan | 10 | <1% |
| United Kingdom | 8 | <1% |
| Germany | 7 | <1% |
| France | 7 | <1% |
| Netherlands | 6 | <1% |
| Italy | 6 | <1% |
| Brazil | 5 | <1% |
| Switzerland | 5 | <1% |
| Other | 32 | <1% |
| Unknown | 4755 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 724 | 15% |
| Researcher | 653 | 13% |
| Student > Bachelor | 560 | 11% |
| Student > Master | 536 | 11% |
| Student > Doctoral Student | 381 | 8% |
| Other | 852 | 17% |
| Unknown | 1174 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 1345 | 28% |
| Biochemistry, Genetics and Molecular Biology | 607 | 12% |
| Agricultural and Biological Sciences | 516 | 11% |
| Neuroscience | 254 | 5% |
| Engineering | 146 | 3% |
| Other | 660 | 14% |
| Unknown | 1352 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 300. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#117,009
of 25,837,817 outputs
Outputs from New England Journal of Medicine
#2,799
of 32,687 outputs
Outputs of similar age
#97
of 78,934 outputs
Outputs of similar age from New England Journal of Medicine
#6
of 177 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.